Comments
FMCG major Dabur India Ltd acquired Ajanta Pharma Ltd's energiser brand 30 Plus. The acquisition is expected to strengthen the FMCG company's position in the healthcare over-the-counter (OTC) space.
“The acquisition of 30 Plus is part of an aggressive strategy to build capability on the OTC healthcare business and I am confident that this transaction will help us in our endeavour to further strengthen our position in this category,” said Mr P.D. Narang, Group Director, Dabur India.
PricewaterhouseCoopers was the advisors to the deal.
Dabur has identified the healthcare OTC segment as an important growth area and has planned a number of initiatives going forward.
Synergies from this deal are expected to help Dabur expand its portfolio and capitalise on the emerging opportunities in the domestic as well as international markets, said Mr Narang.
30 Plus is an energiser brand targeted towards males in the 30-plus age group.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.